| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) | 
|---|
| 11/02/2000 | EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors | 
| 11/02/2000 | EP0888316B1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors | 
| 11/02/2000 | DE19919218A1 New peptide compounds, e.g. aza-heterocyclic substituted beta-alanine derivatives, are integrin receptor antagonists useful e.g. for treating atherosclerosis, cancer, osteoporosis, hypertension or inflammation | 
| 11/02/2000 | CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands | 
| 11/01/2000 | CN1272109A Process for producing isooxazolidinedione compound | 
| 10/31/2000 | US6140506 Intermediates for producing a cis-1-amino-2-indanol | 
| 10/31/2000 | US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides | 
| 10/31/2000 | US6140366 Anticonvulsant therapy for central nervous system disorders, e.g., epilepsy, huntington's chorea, cerebral ischemia, parkinson's disease, tardive dyskinesia, antispasmodic and psychotic disorders; antidepressant, anxiolytic agents | 
| 10/31/2000 | US6140362 Method for inhibiting the growth of mammalian cells | 
| 10/31/2000 | US6140051 Fluorescent dibenzazole derivatives and methods related thereto | 
| 10/26/2000 | WO2000063329A1 Fragrance raw materials aldehydes and pro-fragrances having a tertiary alpha carbon atom | 
| 10/26/2000 | WO2000063180A1 Bis-benzazoles and their use as antineoplastic agents | 
| 10/26/2000 | WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands | 
| 10/26/2000 | WO2000062778A1 Cyclic protein tyrosine kinase inhibitors | 
| 10/26/2000 | WO2000026197A9 Novel inhibitors of impdh enzyme | 
| 10/25/2000 | EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis | 
| 10/25/2000 | CN1271358A Oxazolidinone derivatives and pharmaceutical compositions | 
| 10/25/2000 | CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof | 
| 10/19/2000 | WO2000061589A1 Novel ligands for chiral catalysis | 
| 10/19/2000 | CA2369043A1 Novel ligands for chiral catalysis | 
| 10/18/2000 | EP1044968A1 6-Amino-2-(thi)oxo-pyrimidin-4-one and 7-amino- 2,3-dihydrooxazolo[2,3-b]pyrimidin-5-one derivatives, their preparation and their use as stabilisers for halogen-containing polymers | 
| 10/18/2000 | EP1044966A1 (Poly)thia-alkyne compounds and their derivatives, compositions containing them and their use | 
| 10/18/2000 | EP1044194A1 Receptor with an affinity for compounds of the oxazoline class | 
| 10/18/2000 | CN1270518A Therapeutic or prophylactic agent for glomerulopathy | 
| 10/18/2000 | CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid | 
| 10/18/2000 | CN1057523C Diphenyl oxazoline derivatives | 
| 10/17/2000 | US6133461 Process for producing amide derivatives and intermediates therefor | 
| 10/17/2000 | US6133308 Synthesis of clasto-lactacystin beta-lactone and analogs thereof | 
| 10/17/2000 | US6133295 Pharmaceutical composition | 
| 10/17/2000 | US6133293 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action; potent depressive effect on diabetic hyperglycemia; 2,4-thiazolidinediones and oxazolidinediones | 
| 10/17/2000 | US6133286 Antagonists; antiinflammatory agents for rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis and other skin disorders, e.g., eczema, erythema, pruritus and acne; stroke, reperfusion injury, grafting | 
| 10/17/2000 | US6133283 Mono- or polyenic carboxylic acid derivatives | 
| 10/12/2000 | WO2000060027A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring | 
| 10/12/2000 | WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD | 
| 10/12/2000 | WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders | 
| 10/12/2000 | WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors | 
| 10/11/2000 | EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases | 
| 10/11/2000 | EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS | 
| 10/11/2000 | EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis | 
| 10/11/2000 | EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS | 
| 10/11/2000 | EP1041977A1 USE OF PPAR-$g(g) ACTIVATORS IN DERMATOLOGY | 
| 10/11/2000 | EP0773930B1 Aromatic amino ethers as pain relieving agents | 
| 10/11/2000 | EP0703971B1 Use of n,n-diacetic alpha-alanine and its salts as biodegradable complexing agents for alkaline earth and heavy metal ions in cleaning compositions for dishwashing | 
| 10/11/2000 | CN1269799A Piperidinylmethyloxazolidinone derivative | 
| 10/11/2000 | CN1269792A Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin-receptor atagonists | 
| 10/10/2000 | US6130337 Enantiomerically enriched α,α-distributed amino acids and method | 
| 10/10/2000 | US6130336 Reacting an oxazolidine with 7-trihaloacetylbaccatin in a solvent; deblocking with ammonia | 
| 10/05/2000 | WO2000058306A1 Substituted benzoylpyrazoles as herbicides | 
| 10/05/2000 | WO2000058293A2 Glucokinase activators | 
| 10/05/2000 | WO2000058291A1 Pesticidal enantiomer-pure 2,4-disubstituted oxazolines | 
| 10/05/2000 | WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof | 
| 10/05/2000 | CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof | 
| 10/05/2000 | CA2368459A1 Substituted benzoylpyrazoles as herbicides | 
| 10/04/2000 | EP1041082A1 Process of peptidic synthesis starting from N-carboxyanhydride amino acids | 
| 10/04/2000 | EP1040105A2 Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents | 
| 10/04/2000 | EP1040102A1 Arylthiazolidinedione derivatives | 
| 10/04/2000 | EP1039914A1 Cyclooxygenase-2 inhibition | 
| 10/04/2000 | EP0569384B2 Fungicides | 
| 10/04/2000 | CN1057089C Process for preparing intermediates for synthesis of antifungal agents | 
| 10/04/2000 | CN1057087C Substituted oxazine and thiazinozolidone anti microorganism agent | 
| 10/03/2000 | US6127568 Phenylacetic acid derivatives, preparation thereof and intermediates thereof, and compositions containing them | 
| 10/03/2000 | US6127546 Process for the preparation of oxazoline compound | 
| 10/03/2000 | US6127373 Method of treating tourette's syndrome and obsessive compulsive disorder | 
| 10/03/2000 | US6127372 Sulfonamide inhibitors of aspartyl protease | 
| 09/28/2000 | WO2000056724A1 Oxazole and thiazole combinatorial libraries | 
| 09/28/2000 | WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists | 
| 09/28/2000 | WO2000056685A1 Methods for the preparation of biphenyl isoxazole sulfonamides | 
| 09/28/2000 | WO2000056331A1 Inhibitors of impdh enzyme | 
| 09/28/2000 | DE19914140A1 Substituierte Benzoylpyrazole Substituted benzoylpyrazoles | 
| 09/28/2000 | CA2368026A1 Oxazole and thiazole combinatorial libraries | 
| 09/28/2000 | CA2367916A1 Methods for the preparation of biphenyl isoxazole sulfonamides | 
| 09/27/2000 | EP1037883A1 NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS | 
| 09/27/2000 | CN1268147A Sprayable coating compositions comprising oxazolidine and isocyanates | 
| 09/27/2000 | CN1056836C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles and producing process thereof and their use as medicaments | 
| 09/27/2000 | CN1056835C Novel selective aromatase inhibiting compounds | 
| 09/26/2000 | US6124343 For treating a patient subject to a disease state associated with a physiological detrimental excess of endothelin or a disease state associated with a pathological condition that is modulated by inhibiting endothelin | 
| 09/26/2000 | US6124313 Imidazopyridine azolidinones | 
| 09/26/2000 | US6124102 Methods for determining receptor-ligand binding using probe arrays | 
| 09/26/2000 | US6124085 Silver halide photographic light-sensitive material having high sensitivity and excellent storability and reduced in fog and residual color | 
| 09/26/2000 | CA2064108C Thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators | 
| 09/21/2000 | WO2000055144A1 Amine derivatives as protease inhibitors | 
| 09/21/2000 | WO2000055143A1 Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators | 
| 09/21/2000 | WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents | 
| 09/21/2000 | WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues | 
| 09/21/2000 | WO2000004865A3 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives | 
| 09/21/2000 | CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues | 
| 09/21/2000 | CA2367352A1 Amine derivatives as protease inhibitors | 
| 09/20/2000 | EP1036075A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties | 
| 09/20/2000 | EP1036074A1 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones | 
| 09/20/2000 | EP1036069A1 Benzenesulfonamide compounds | 
| 09/20/2000 | EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors | 
| 09/20/2000 | EP1036060A2 Cyclohexadiene-derivatives as pesticides | 
| 09/20/2000 | EP1035845A1 Modulators of cysteine protease | 
| 09/20/2000 | EP1035843A2 I h?-MODULATORS | 
| 09/19/2000 | US6121303 Such as 4-((3,4-dihydroxy-5-nitrophenyl)methylidene)-2,5-imidazolidindione; medicinal antioxidants for treatment or prevention of tissue damage caused by lipid peroxidation | 
| 09/19/2000 | US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin | 
| 09/19/2000 | US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction | 
| 09/14/2000 | WO2000053589A1 Process for preparing oxazole derivatives | 
| 09/14/2000 | WO2000053571A1 PROCESSES FOR THE PREPARATION OF α-AMINOKETONES | 
| 09/14/2000 | WO2000053547A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |